Stress in Pregnancy During the Covid19 Pandemic and Impact on the Newborn Neurodevelopment

F

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Status

Active, not recruiting

Conditions

Covid19 and Pregnancy

Treatments

Other: biological
Other: Severity of infection, time of infection.
Other: Mental health assessment

Study type

Observational

Funder types

Other

Identifiers

NCT06362486
SIGNATURE

Details and patient eligibility

About

The Covid19 pandemic, paradoxically, represents a valuable opportunity to carry out cohort studies that allow us to advance our knowledge about the relationship between inflammation, brain development and an increased risk of suffering from neuropsychiatric disorders or alterations. In addition, the current availability of sophisticated biological techniques and evaluation procedures represents an unique option for this purpose. Here, we propose a cohort study of sars-cov-2 (type 2 coronavirus causing severe acute respiratory syndrome) infected pregnant women and newborns. We will try to answer the following questions: (i) what is the inflammatory / immune status of newborns (NBs) of mothers infected by Covid19 like?; (ii) is there a relationship between the clinical characteristics of the maternal infection (severity / moment / of infection) and the inflammatory status of the newborn?; (iii) could these features increase the vulnerability to developing central nervous system (CNS) alterations at an early age, and at some point during adult life ?; (iv) How is the Covid19 infected mother's placenta altered? Do the placental alterations Covid19 mediated contribute to develop CNS alterations?; (v) is the infection associated with phenotypes obtained through neurological and neurodevelopmental clinical evaluation (hypotonia, clumsiness, impaired communication and sociability) in children at 6 months and 12 months? Our main objective is to explore how the presence of stressors and prenatal sars-cov-2 infection generates an abnormal inflammatory activity in the newborn, which is associated with neurodevelopmental disorders and which confers a greater risk of developing neuropsychiatric disorders. The biological information of the umbilical cord (fetus blood) and peripheral blood of the mother obtained after childbirth was provided by the cohort of women during the Covid19 pandemic monitored during their pregnancy, delivery, childbirth and postpartum. These samples and the clinical characterisation of the cohort of mothers and newborns, of which we will be able to do an exhaustive longitudinal follow-up, are tremendously valuable at this time. There is a need to establish new research strategies to understand the pathophysiology of neuropsychiatric diseases, and to discover new molecular and cellular mechanisms involved in the development of the CNS.

Enrollment

1,000 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 1. over 18 years old
  • 2. Ultrasound-confirmed pregnancy
  • 3. infected (past or present) or non-infected with Covid19

Exclusion criteria

  • 1. presents alcohol abuse during pregnancy
  • 2. other concomitant causes of risk of demonstrated neurodevelopmental disorders
  • 3. presents drug abuse except tobacco during pregnancy
  • 4. under 18 years of age

Trial design

1,000 participants in 3 patient groups

Cohort A N=1000
Description:
neurodevelopment assessment by pediatrician, need to refer to neurodevelopmental assessment by specialized team. m-chat. autism diagnosis.
Treatment:
Other: Severity of infection, time of infection.
Cohort B N=500
Description:
Mental health assessment
Treatment:
Other: Mental health assessment
Cohort C N=100
Description:
biological
Treatment:
Other: biological

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems